「Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab」の関連論文
-
腸管ベーチェット病患者に対する抗TNFα抗体製剤の有効性と予測因子
-
The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
Phase II study of nab-paclitaxel plus cyclophosphamide plus trastuzumab neoadjuvant chemotherapy in early HER-2-positive breast cancer
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
Study on the clinical outcome and molecular changes of precursor-targeted immune-mediated anemia treated with splenectomy [an abstract of entire text]
-
Serological Cytokine Signature in Paediatric Patients with Inflammatory Bowel Disease Impacts Diagnosis
-
The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
-
非小細胞肺がん患者におけるオシメルチニブ有害事象とSTAT3, CYP3A5, ABCG2遺伝子多型との関連
-
EGFR-TKI耐性と腫瘍内組織免疫微小環境との相互作用についての検討
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
悪性リンパ腫における血中循環細胞外遊離DNAを用いたゲノム解析に関する研究
-
Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation
-
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
-
前立腺生検組織におけるDSGb5糖鎖発現の臨床的意義について
-
The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma
-
The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer
-
転移または再発乳癌の末梢血循環DNA変異解析の検討
-
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
-
膀胱癌におけるエストロゲンレセプターβとシスプラチン耐性獲得機序についての研究
-
Role of PD-L1 expression during the progression of submucosal gastric cancer
-
がん化学療法における副作用管理とリスク因子の探索に関する研究
-
KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma
-
分子標的抗がん薬の血中濃度情報を活用した腎癌治療の個別最適化に関する研究
-
胃癌におけるCD44 variant 9の発現は、細胞内活性酸素種の蓄積を制御し、化学療法抵抗性を誘導する
-
Evaluation of Time to Failure of Strategy as an Alternative Surrogate Endpoint in Lung Cancer Patients with EGFR Mutations.
-
化学療法後の大腸癌肝転移におけるMRIを用いた腫瘍内脂質検出の臨床的意義
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Early volume loss of skeletal muscle after esophagectomy : a risk for late-onset postoperative pneumonia
-
上部消化管癌に対する第三世代がん治療用ヘルペスウイルス(G47Δ)の治療効果の検討
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial
-
初発単発肝細胞癌に対する肝切除と粒子線治療成績の比較:2施設間での傾向スコアマッチング解析を用いた検討
-
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
-
Impact of Pleural Thickness on Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma
-
Clinical significance of topoisomerase-II expression in patients with advanced Non-Small Cell Lung Cancer treated with amrubicin
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
肝細胞癌患者におけるレンバチニブの治療効果ならびに副作用発現に対する薬物血中濃度モニタリングの有用性に関する研究
-
中等症紫斑病性腎炎の小児患者に対するレニン-アンジオテンシン系阻害薬による初回治療の効果
-
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
-
免疫チェックポイント阻害薬使用患者の癌種横断的レジストリの構築、ならびに治療効果・免疫関連有害事象発現の予測に関する研究
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
局所進行頭頸部扁平上皮癌における予防的リンパ節照射線量の検討:プロペンシティスコア・マッチング解析
-
腹膜播種陽性または腹腔細胞診陽性の胃癌に対する集学的治療の開発